{"version":"1.0","type":"link","title":"[Current status and controversies of thyroid stimulating hormone suppression therapy in low-risk differentiated thyroid carcinoma].","author_name":"Ma ZT 외","author_url":"https://prs-insight.online/author/Ma%20ZT","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/79677","thumbnail_width":1200,"thumbnail_height":630}